Recent Advances in Pharmaceutical and Medical Applications in the Area of Selected Porphyrinoids Connected with PLGA or PLGA-Based Modalities

-glycolic acid, PLGA)-based polymeric nanoparticles encapsulating selected well-known photosensitizers, such as protoporphyrin IX, tetrahydroxyphenylporphyrin, chlorin e6, and tetracarboxyphenylporphyrin, with a view to the physicochemical and biological properties. Also discussed are their potential medical applications towards photodynamic and sonodynamic therapy. PLGA-based nanoparticles, encapsulating photosensitizers, were analysed in terms of particle size, surface charge, morphology, loading efficiency, release kinetics, and stability. Moreover, the cellular uptake and subcellular localisation of carriers were considered in correlation to polymer composition and surface functionalisation. Special attention was given to how PEGylation, lipid-hybrid coatings, or the incorporation of additional therapeutic or imaging agents has modulated both the physicochemical properties and biological activities of photosensitizers. The comparative assessment of different porphyrinoid-based photosensitizers highlighted how hydrophobicity, amphiphilicity, and molecular structure have an influence on encapsulation efficiency and therapeutic outcomes. Furthermore, issues such as the premature release of photosensitizers, along with limited bioavailability, and limited penetration through biological barriers were addressed as well as some proposed mitigation strategies. Overall, this review highlights the versatility of PLGA nanoparticles as a powerful platform for photosensitizer delivery, with promising implications for advancing polymer-based nanomedicine and improving the efficacy of photodynamic therapy.